Top Markets
Coin of the day
Lexaria Bioscience Corp. Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXW
株式のランク #41277
Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation... Lexaria Bioscience Corp. is a biotechnology firm specializing in the creation and licensing of its patented drug delivery system, DehydraTECH. This innovative technology functions by integrating fat-soluble compounds or active pharmaceutical ingredients (APIs) with particular long-chain fatty acids and specific carrier substances. The aim of this process is to significantly boost their entry into the bloodstream, consequently enhancing their effectiveness, enabling lower overall dosages, and supporting healthier methods of oral consumption. DehydraTECH can be utilized with a broad spectrum of active molecules, including fat-soluble vitamins, pain relievers, hormones, PDE5 inhibitors, antiviral agents, oral nicotine and its analogues, and various cannabinoids. The company is also investigating DehydraTECH's potential therapeutic applications for conditions such as high blood pressure, cardiovascular diseases, and diabetes. Its versatility renders it suitable for integration into diverse product categories, encompassing pharmaceuticals, nutraceuticals, over-the-counter remedies, and consumer packaged goods. Established in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.
株価
$0.0012
最終同期: 2026-01-13
時価総額
$29.83K
変化(1日)
-77.36%
変化(1年)
-98.91%
US
取引 Lexaria Bioscience Corp. (LEXXW)

カテゴリー

Lexaria Bioscience Corp.(LEXXW)の配当利回りの履歴
Lexaria Bioscience Corp.(銘柄コード: LEXXW)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Lexaria Bioscience Corp.(LEXXW)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)